Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the tolerability of Cetaphil® DermaControlâ„¢ Foam Wash and Moisturizer SPF 30 in pediatric subjects (7-11) with acne prone skin.


Clinical Trial Description

This was a open-label, single center study conducted in the United States that evaluated the tolerability of Cetaphil® DermaControlâ„¢ skin care products used at least once daily for 22 days in male and female subjects age 7 to 11 with acne prone skin. There were 4 visits during the course of the study: screening (within 7 days of visit 1), visit 1(baseline /day1), visit 2 (day 8), and visit 3 (day 22/exit). Tolerability assessments were performed by a board certified dermatologist at all visits. Subjects completed the baseline skin care regimen questionnaire at visit 1. Hydration assessments were competed at visits 1, 2, and 3. A subject satisfaction questionnaire was completed at visit 3. Adverse event assessments were conducted for all subjects at every clinic visit after informed consent/assent was signed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01909713
Study type Interventional
Source Galderma R&D
Contact
Status Completed
Phase Phase 4
Start date May 2013
Completion date June 2013